Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
gptkb:Hexal_AG
gptkb:Eon_Labs gptkb:Apex_Pharma gptkb:Zentiva |
| gptkbp:awards |
various industry awards
|
| gptkbp:categories |
gptkb:diabetes
gptkb:surgery metabolic disorders neurology oncology pediatrics antibiotics antivirals central nervous system antihistamines orthopedics anticoagulants antifungals antiparasitics psychiatry vaccines dermatology biologics hormonal therapies infectious diseases antidepressants immunology pain management antipsychotics analgesics antihypertensives ophthalmology immunosuppressants biosimilars urology gastroenterology cardiovascular respiratory anticonvulsants narcotics antiseptics contraceptives antidiabetics antimicrobials antineoplastics antiseizure medications |
| gptkbp:ceo |
Richard Francis
|
| gptkbp:focus |
affordable medicines
|
| gptkbp:founded |
1886
|
| gptkbp:founder |
Emil Barell
|
| gptkbp:headquarters |
gptkb:Holzkirchen,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sandoz Ltd.
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:market_position |
over 160 countries
|
| gptkbp:number_of_employees |
over 10,000
|
| gptkbp:parent_company |
gptkb:Novartis
|
| gptkbp:part_of |
gptkb:Novartis_Group
|
| gptkbp:partnership |
various healthcare organizations
|
| gptkbp:products |
generic drugs
biosimilars |
| gptkbp:region |
global
|
| gptkbp:research_and_development |
biopharmaceuticals
generic pharmaceuticals |
| gptkbp:revenue |
approximately $10 billion
|
| gptkbp:subsidiary |
gptkb:Sandoz_UK_Ltd.
gptkb:Sandoz_Australia_Pty_Ltd. gptkb:Sandoz_Gmb_H gptkb:Sandoz_Canada_Inc. |
| gptkbp:sustainability_initiatives |
social responsibility
environmental responsibility access to medicines |
| gptkbp:website |
www.sandoz.com
|
| gptkbp:bfsParent |
gptkb:Clariant_AG
|
| gptkbp:bfsLayer |
6
|